miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting. Minini M, Senni A, He X, Proietti S, et al. Cancer Lett 2021 Jul 3. pii: S0304-3835(21)00326.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Minini M, Senni A, He X, Proietti S, et al. miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting. Cancer Lett 2021 Jul 3. pii: S0304-3835(21)00326.
PMID: 34229060